Literature DB >> 10868705

Use of pleural fluid C-reactive protein in diagnosis of pleural effusions.

U Yilmaz Turay1, Z Yildirim, Y Türköz, C Biber, Y Erdoğan, A I Keyf, F Uğurman, A Ayaz, P Ergün, M Harputluoğlu.   

Abstract

The aims of the study were to assess whether C-reactive protein (CRP) is a sensitive marker for discriminating between transudative and exudative and pleural effusions to evaluate whether it can be used to distinguish inflammatory pleural effusions from other types of effusion. Pleural fluid and serum CRP levels were obtained in 97 patients with pleural effusion, using an immunoturbidimetric method (Olympus AU-600 autoanalyser). We compared CRP levels between transudates and exudates, inflammatory effusions and other types of effusion. According to the criteria used, 16 patients were included in the transudate group and 81 patients in the exudate group. Pleural fluid CRP levels were significantly lower in the transudate group (P<0.04; 14.9 +/- 4.9 mg l(-1) and 35.5 +/- 4.9 mg l(-1) respectively). Also, the ratio of pleural fluid to serum was significantly lower in the transudate group (P<0.009; 0.8 +/- 0.5 mg l(-1) and 2.8 +/- 0.7 mg l(-1), respectively). In the exudate group, 35 patients had neoplastic effusions, 10 chronic non-specific pleurisy, 19 tuberculous pleurisy, 16 parapneumonic effusion and one Dressler Syndrome. When these sub-groups were compared, the parapneumonic effusion subgroup CRP levels (mean 89 +/- 16.3 mg l(-1)) were significantly higher than those in the other subgroups, other exudate of neoplastic effusion, tuberculous pleurisy and chronic non-specific effusion and the transudate group (P<0.0001; P<0.0001; P<0.0004 and P<0.0001, respectively). The ratio between pleural fluid and serum CRP was significantly higher in the parapneumonic effusion subgroup than in the neoplastic subgroup (P<0.0002; 6.6 +/- 2.7 mg l(-1) and 1 +/- 0.2 mg l(-1), respectively). Pleural fluid CRP levels > 30 mg l(-1) had a high sensitivity (93.7%) and specificity (76.5%) and a positive predictive value of 98.4%. In the differential diagnosis of pleural effusions, higher CRP levels may prove to be a rapid, practical and accurate method of differentiating parapneumonic effusions from other exudate types. Although the high level of CRP obtained in the exudate group may be due to the number of patients with parapneumonic effusion who were included, the pleural CRP level may also be helpful in discriminating between exudative and transudative pleural effusions.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10868705     DOI: 10.1053/rmed.1999.0759

Source DB:  PubMed          Journal:  Respir Med        ISSN: 0954-6111            Impact factor:   3.415


  13 in total

1.  A potential role for VEGF in the diagnostic approach of pleural effusions.

Authors:  Aggeliki Psatha; Demosthenes Makris; Theodora Kerenidi; Zoe Daniil; Theodoros Kiropoulos; Konstantinos Gourgoulianis
Journal:  J Thorac Dis       Date:  2016-07       Impact factor: 2.895

2.  Role of pleural fluid C-reactive protein concentration in discriminating uncomplicated parapneumonic pleural effusions from complicated parapneumonic effusion and empyema.

Authors:  S C Chen; W Chen; W H Hsu; Y H Yu; C M Shih
Journal:  Lung       Date:  2006 May-Jun       Impact factor: 2.584

3.  The Role of Pleural Fluid C-Reactive Protein in the Diagnosis of Exudative Pleural Effusions.

Authors:  Sanket Makwana; Prashant Gohil; Yash Gabhawala
Journal:  Cureus       Date:  2022-07-19

4.  Diagnostic performance of C-reactive protein for parapneumonic pleural effusion: a meta-analysis.

Authors:  Dajiang Li; Yongchun Shen; Jiangyue Qin; Chun Wan; Ni Zeng; Lei Chen; Yue Dong
Journal:  Ann Transl Med       Date:  2019-01

5.  Tumor necrosis factor alpha and high sensitivity C-reactive protein in diagnosis of exudative pleural effusion.

Authors:  Fariba Rezaeetalab; Seyed Mohhamad Reza Parizadeh; Habibollah Esmaeely; Hadi Akbari; Farzaneh Akbari; Soheila Saberi
Journal:  J Res Med Sci       Date:  2011-11       Impact factor: 1.852

6.  Pleural fluid analysis: standstill or a work in progress?

Authors:  T Hassan; M Al-Alawi; S H Chotirmall; N G McElvaney
Journal:  Pulm Med       Date:  2012-02-01

7.  The acute-phase proteins serum amyloid A and C reactive protein in transudates and exudates.

Authors:  Alessandra M Okino; Cristiani Bürger; Jefferson R Cardoso; Edson L Lavado; Paulo A Lotufo; Ana Campa
Journal:  Mediators Inflamm       Date:  2006       Impact factor: 4.711

8.  Pleural fluid pentraxin-3 for the differential diagnosis of pleural effusions.

Authors:  Chang Dong Yeo; Jin Woo Kim; Mi Ran Cho; Ji Young Kang; Seung Joon Kim; Young Kyoon Kim; Sang Haak Lee; Chan Kwon Park; Sang Ho Kim; Mi Sun Park; Hyeon Woo Yim; Jong Y Park
Journal:  Tuberc Respir Dis (Seoul)       Date:  2013-12-24

9.  Diagnostic value and prognostic significance of pleural C-reactive protein in lung cancer patients with malignant pleural effusions.

Authors:  Do-Sim Park; Dong Kim; Ki-Eun Hwang; Yu-Ri Hwang; Chul Park; Chang-Hwan Seol; Kyung-Hwa Cho; Byoung-Ryun Kim; Seong-Hoon Park; Eun-Taik Jeong; Hak-Ryul Kim
Journal:  Yonsei Med J       Date:  2013-03-01       Impact factor: 2.759

10.  Efficacy of procalcitonin and pentraxin-3 as early biomarkers for differential diagnosis of pleural effusions.

Authors:  Anita Sharma; Apurva Agrawal; Girish Sindhwani; Ashish Sharma; Sojit Tomo; Jaykaran Charan; Dharmveer Yadav; Praveen Sharma
Journal:  Pleura Peritoneum       Date:  2021-04-19
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.